Asenapine-induced restless legs syndrome: differentiation from akathisia
- PMID: 25325577
- PMCID: PMC4237529
- DOI: 10.5664/jcsm.4296
Asenapine-induced restless legs syndrome: differentiation from akathisia
Abstract
Akathisia and restless legs syndrome (RLS) share some common clinical features and a common relationship with dopamine dysfunction. However, the underlying causes and appropriate treatments for akathisia and RLS are different. Herein we describe a case of RLS that was precipitated by a single dose of asenapine, which is an atypical antipsychotic, and dissect the features that support the contention that this was indeed a case of RLS and not akathisia.
Keywords: akathisia; asenapine; restless leg syndrome.
© 2014 American Academy of Sleep Medicine.
Similar articles
-
Restless leg syndrome associated with atypical antipsychotics: current status, pathophysiology, and clinical implications.Curr Drug Saf. 2015;10(2):98-105. doi: 10.2174/1574886309666140527114159. Curr Drug Saf. 2015. PMID: 24861990 Review.
-
A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.Sleep. 1991 Aug;14(4):339-45. Sleep. 1991. PMID: 1682986
-
Restless leg syndrome associated with olanzapine: a case series.Curr Drug Saf. 2010 Apr;5(2):129-31. doi: 10.2174/157488610790936187. Curr Drug Saf. 2010. PMID: 20406161
-
Restless legs syndrome and akathisia as manifestations of acute pontine infarction.J Clin Neurosci. 2014 Feb;21(2):354-5. doi: 10.1016/j.jocn.2013.03.021. Epub 2013 Aug 15. J Clin Neurosci. 2014. PMID: 23953640
-
[Drug-induced akathisia].Ned Tijdschr Geneeskd. 2002 Jan 19;146(3):110-4. Ned Tijdschr Geneeskd. 2002. PMID: 11826669 Review. Dutch.
Cited by
-
Safety assessment of asenapine in the FAERS database: real adverse event analysis and discussion on neurological and psychiatric side effects.BMC Pharmacol Toxicol. 2024 Aug 12;25(1):49. doi: 10.1186/s40360-024-00772-4. BMC Pharmacol Toxicol. 2024. PMID: 39135183 Free PMC article.
-
Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024.Nat Sci Sleep. 2025 May 15;17:929-946. doi: 10.2147/NSS.S513538. eCollection 2025. Nat Sci Sleep. 2025. PMID: 40391202 Free PMC article.
-
The Other Obesity Epidemic-Of Drugs and Bugs.Front Endocrinol (Lausanne). 2020 Jul 31;11:488. doi: 10.3389/fendo.2020.00488. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32849279 Free PMC article. Review.
References
-
- Allen R, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19. - PubMed
-
- Cervenka S, Palhagen S, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017–28. - PubMed
-
- American Psychiatric Association. 5th ed. Arlington, VA: American Psychiatric Association; 2013. Diagnostic and Statistical Manual of Mental Disorders.
-
- Kumar R, Sachdev PS. Akathisia and second-generation antipsychotic drugs. Curr Opin Psychiatry. 2009;22:293–9. - PubMed
-
- Benes H, Walters AS, Allen RP, et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22:S401–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical